SU‐GG‐T‐507

Clinically Derived Dose‐Response Relations for Prostate from Combined Photon and Proton Prostate Cancer Radiotherapy

P. Mavroidis, C. Valianti, I. Boumpoutsi, U. Isacsson, S. Johansson, A. Montelius, Nikos Papanikolaou, G. Sakellaropoulos, G. Nikiforidis, I. Turesson, B. Lind

Research output: Contribution to journalArticle

Abstract

Purpose Recent advances in radiation therapy have provided the possibility of combining different modalities in different parts of the treatment. The purpose of this study was the determination of the parameters D50 and γ for the prostate adenocarcinoma using different radiobiological models, when proton and photon beams are combined. Material and Methods In this study 100 patients, who were treated for prostate cancer at the Academic Hospital in Uppsala, Sweden from 2002 to 2006, were used. The patients were treated with a conventional photon beam configuration to a dose of 50 Gy in 2 Gy fractions. Additionally, a proton boost of 20 Gy in 5 Gy fractions was applied. The photon and proton doses were corrected for the fractionation effects using the BED (biologically effective dose) concept. In the calculation of the proton dose, we considered RBE=1.1. For each patient, the clinical treatment outcome (follow‐up of 24 months) and the 3D dose distribution delivered to the target were available. The best estimates of the parameters D50 and γ of the Binomial, Poisson and Probit models were determined by applying a maximum likelihood fitting. Results Of the 100 patients, 94 had tumor control (94.0%) whereas 6 patients had treatment failure (6.0%). The mean doses in the prostate in these two groups of patients were 72.97Gy and 62.60Gy, respectively. The estimated values of the parameters for the Poisson and Binomial models are D50=49.6Gy (68%CI=47.1–51.9Gy) and γ=2.25 (68%CI=1.83–2.75), whereas for the Probit model they are D50=47.3Gy (68%CI=45.1–49.4Gy) and γ=1.31 (68%CI=1.11–1.52). Conclusions The estimated parameters are able to describe the dose‐response relation of prostate adenocarcinoma. Since there are very limited data on radiation therapy using combinations of photon and proton beams, the determined parameters can be useful in estimating the expected clinical outcome during treatment planning and perform optimization of the delivered treatment.

Original languageEnglish (US)
Pages (from-to)3303
Number of pages1
JournalMedical Physics
Volume37
Issue number6
DOIs
StatePublished - 2010

Fingerprint

Photons
Protons
Prostate
Prostatic Neoplasms
Radiotherapy
Adenocarcinoma
Statistical Models
Treatment Failure
Sweden
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Mavroidis, P., Valianti, C., Boumpoutsi, I., Isacsson, U., Johansson, S., Montelius, A., ... Lind, B. (2010). SU‐GG‐T‐507: Clinically Derived Dose‐Response Relations for Prostate from Combined Photon and Proton Prostate Cancer Radiotherapy. Medical Physics, 37(6), 3303. https://doi.org/10.1118/1.3468903

SU‐GG‐T‐507 : Clinically Derived Dose‐Response Relations for Prostate from Combined Photon and Proton Prostate Cancer Radiotherapy. / Mavroidis, P.; Valianti, C.; Boumpoutsi, I.; Isacsson, U.; Johansson, S.; Montelius, A.; Papanikolaou, Nikos; Sakellaropoulos, G.; Nikiforidis, G.; Turesson, I.; Lind, B.

In: Medical Physics, Vol. 37, No. 6, 2010, p. 3303.

Research output: Contribution to journalArticle

Mavroidis, P, Valianti, C, Boumpoutsi, I, Isacsson, U, Johansson, S, Montelius, A, Papanikolaou, N, Sakellaropoulos, G, Nikiforidis, G, Turesson, I & Lind, B 2010, 'SU‐GG‐T‐507: Clinically Derived Dose‐Response Relations for Prostate from Combined Photon and Proton Prostate Cancer Radiotherapy', Medical Physics, vol. 37, no. 6, pp. 3303. https://doi.org/10.1118/1.3468903
Mavroidis, P. ; Valianti, C. ; Boumpoutsi, I. ; Isacsson, U. ; Johansson, S. ; Montelius, A. ; Papanikolaou, Nikos ; Sakellaropoulos, G. ; Nikiforidis, G. ; Turesson, I. ; Lind, B. / SU‐GG‐T‐507 : Clinically Derived Dose‐Response Relations for Prostate from Combined Photon and Proton Prostate Cancer Radiotherapy. In: Medical Physics. 2010 ; Vol. 37, No. 6. pp. 3303.
@article{f08b967513f04f33bc94deb81f284f76,
title = "SU‐GG‐T‐507: Clinically Derived Dose‐Response Relations for Prostate from Combined Photon and Proton Prostate Cancer Radiotherapy",
abstract = "Purpose Recent advances in radiation therapy have provided the possibility of combining different modalities in different parts of the treatment. The purpose of this study was the determination of the parameters D50 and γ for the prostate adenocarcinoma using different radiobiological models, when proton and photon beams are combined. Material and Methods In this study 100 patients, who were treated for prostate cancer at the Academic Hospital in Uppsala, Sweden from 2002 to 2006, were used. The patients were treated with a conventional photon beam configuration to a dose of 50 Gy in 2 Gy fractions. Additionally, a proton boost of 20 Gy in 5 Gy fractions was applied. The photon and proton doses were corrected for the fractionation effects using the BED (biologically effective dose) concept. In the calculation of the proton dose, we considered RBE=1.1. For each patient, the clinical treatment outcome (follow‐up of 24 months) and the 3D dose distribution delivered to the target were available. The best estimates of the parameters D50 and γ of the Binomial, Poisson and Probit models were determined by applying a maximum likelihood fitting. Results Of the 100 patients, 94 had tumor control (94.0{\%}) whereas 6 patients had treatment failure (6.0{\%}). The mean doses in the prostate in these two groups of patients were 72.97Gy and 62.60Gy, respectively. The estimated values of the parameters for the Poisson and Binomial models are D50=49.6Gy (68{\%}CI=47.1–51.9Gy) and γ=2.25 (68{\%}CI=1.83–2.75), whereas for the Probit model they are D50=47.3Gy (68{\%}CI=45.1–49.4Gy) and γ=1.31 (68{\%}CI=1.11–1.52). Conclusions The estimated parameters are able to describe the dose‐response relation of prostate adenocarcinoma. Since there are very limited data on radiation therapy using combinations of photon and proton beams, the determined parameters can be useful in estimating the expected clinical outcome during treatment planning and perform optimization of the delivered treatment.",
author = "P. Mavroidis and C. Valianti and I. Boumpoutsi and U. Isacsson and S. Johansson and A. Montelius and Nikos Papanikolaou and G. Sakellaropoulos and G. Nikiforidis and I. Turesson and B. Lind",
year = "2010",
doi = "10.1118/1.3468903",
language = "English (US)",
volume = "37",
pages = "3303",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐GG‐T‐507

T2 - Clinically Derived Dose‐Response Relations for Prostate from Combined Photon and Proton Prostate Cancer Radiotherapy

AU - Mavroidis, P.

AU - Valianti, C.

AU - Boumpoutsi, I.

AU - Isacsson, U.

AU - Johansson, S.

AU - Montelius, A.

AU - Papanikolaou, Nikos

AU - Sakellaropoulos, G.

AU - Nikiforidis, G.

AU - Turesson, I.

AU - Lind, B.

PY - 2010

Y1 - 2010

N2 - Purpose Recent advances in radiation therapy have provided the possibility of combining different modalities in different parts of the treatment. The purpose of this study was the determination of the parameters D50 and γ for the prostate adenocarcinoma using different radiobiological models, when proton and photon beams are combined. Material and Methods In this study 100 patients, who were treated for prostate cancer at the Academic Hospital in Uppsala, Sweden from 2002 to 2006, were used. The patients were treated with a conventional photon beam configuration to a dose of 50 Gy in 2 Gy fractions. Additionally, a proton boost of 20 Gy in 5 Gy fractions was applied. The photon and proton doses were corrected for the fractionation effects using the BED (biologically effective dose) concept. In the calculation of the proton dose, we considered RBE=1.1. For each patient, the clinical treatment outcome (follow‐up of 24 months) and the 3D dose distribution delivered to the target were available. The best estimates of the parameters D50 and γ of the Binomial, Poisson and Probit models were determined by applying a maximum likelihood fitting. Results Of the 100 patients, 94 had tumor control (94.0%) whereas 6 patients had treatment failure (6.0%). The mean doses in the prostate in these two groups of patients were 72.97Gy and 62.60Gy, respectively. The estimated values of the parameters for the Poisson and Binomial models are D50=49.6Gy (68%CI=47.1–51.9Gy) and γ=2.25 (68%CI=1.83–2.75), whereas for the Probit model they are D50=47.3Gy (68%CI=45.1–49.4Gy) and γ=1.31 (68%CI=1.11–1.52). Conclusions The estimated parameters are able to describe the dose‐response relation of prostate adenocarcinoma. Since there are very limited data on radiation therapy using combinations of photon and proton beams, the determined parameters can be useful in estimating the expected clinical outcome during treatment planning and perform optimization of the delivered treatment.

AB - Purpose Recent advances in radiation therapy have provided the possibility of combining different modalities in different parts of the treatment. The purpose of this study was the determination of the parameters D50 and γ for the prostate adenocarcinoma using different radiobiological models, when proton and photon beams are combined. Material and Methods In this study 100 patients, who were treated for prostate cancer at the Academic Hospital in Uppsala, Sweden from 2002 to 2006, were used. The patients were treated with a conventional photon beam configuration to a dose of 50 Gy in 2 Gy fractions. Additionally, a proton boost of 20 Gy in 5 Gy fractions was applied. The photon and proton doses were corrected for the fractionation effects using the BED (biologically effective dose) concept. In the calculation of the proton dose, we considered RBE=1.1. For each patient, the clinical treatment outcome (follow‐up of 24 months) and the 3D dose distribution delivered to the target were available. The best estimates of the parameters D50 and γ of the Binomial, Poisson and Probit models were determined by applying a maximum likelihood fitting. Results Of the 100 patients, 94 had tumor control (94.0%) whereas 6 patients had treatment failure (6.0%). The mean doses in the prostate in these two groups of patients were 72.97Gy and 62.60Gy, respectively. The estimated values of the parameters for the Poisson and Binomial models are D50=49.6Gy (68%CI=47.1–51.9Gy) and γ=2.25 (68%CI=1.83–2.75), whereas for the Probit model they are D50=47.3Gy (68%CI=45.1–49.4Gy) and γ=1.31 (68%CI=1.11–1.52). Conclusions The estimated parameters are able to describe the dose‐response relation of prostate adenocarcinoma. Since there are very limited data on radiation therapy using combinations of photon and proton beams, the determined parameters can be useful in estimating the expected clinical outcome during treatment planning and perform optimization of the delivered treatment.

UR - http://www.scopus.com/inward/record.url?scp=85024792071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024792071&partnerID=8YFLogxK

U2 - 10.1118/1.3468903

DO - 10.1118/1.3468903

M3 - Article

VL - 37

SP - 3303

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -